scispace - formally typeset
J

James H. Gerlach

Researcher at Queen's University

Publications -  20
Citations -  4939

James H. Gerlach is an academic researcher from Queen's University. The author has contributed to research in topics: Multiple drug resistance & Gene expression. The author has an hindex of 14, co-authored 20 publications receiving 4845 citations. Previous affiliations of James H. Gerlach include University of Arizona.

Papers
More filters
Journal ArticleDOI

Structural organization of the human TOP2A and TOP2B genes.

TL;DR: In this paper, the intron-exon structures of TOP2A and TOP2B have been defined and the amino-acid sequences of the two proteins were aligned, showing that the two genes are highly conserved except for the regions encoding the extreme NH2 and COOH termini of the proteins.
Journal ArticleDOI

Bipartite Nuclear Localization Signals in the C Terminus of Human Topoisomerase IIα

TL;DR: The results confirm that a broader definition is required to detect all potential bipartite NLS motifs in a polypeptide sequence, although functional tests are still essential for identification of those sequences actually capable of directing nuclear localization.
Journal ArticleDOI

Sequence determinants of nuclear localization in the alpha and beta isoforms of human topoisomerase II.

TL;DR: It is shown that human topo IIalpha tagged with green fluorescence protein is still detectable in the nucleus when alphaNLS(1454-1497) has been disrupted, and differences in the NLS sequences of humanTopo II isoforms may contribute to their differences in subnuclear localization.
Journal ArticleDOI

Multidrug resistance genes (MRP) and MDR1 expression in small cell lung cancer xenografts: relationship with response to chemotherapy

TL;DR: The remarkably high levels and frequency of MRP expression in some SCLC samples indicate that future developments in chemotherapy of this tumour type should anticipate that drugs which are substrates of MRp may be of limited effectiveness.
Journal ArticleDOI

Simultaneous Quantitation of Topoisomerase II α and β Isoform mRNAs in Lung Tumor Cells and Normal and Malignant Lung Tissue

TL;DR: A semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) assay to measure levels of topo II α and β mRNAs simultaneously using a single pair of primers with sequences common to both isoforms is developed, and for the first time, makes the rapid simultaneous direct comparison oftopo IIα and topoIIβ mRNA levels feasible in large numbers of clinical samples.